Skip to main content
. 2020 May 26;17(11):3760. doi: 10.3390/ijerph17113760

Table 4.

Comparisons of outcome between groups in blood biomarker at baseline and 12 weeks.

Blood Biomarker Control Groupleft
(n = 32)
MCEP Groupleft
(n = 32)
Group × Time #
Baseline 12-Weeks Baseline 12-Weeks p
IL-6 11.93 ± 17.56 11.04 ± 8.93 10.15 ± 6.25 8.16 ± 8.58 0.005
CRP 3.97± 5.82 4.60 ± 6.91 3.83 ± 5.13 2.49 ± 4.46 0.022

All data are expressed as means ± SD; # Analysis of two-way repeated-measures ANOVA. = Significant difference between baseline and post-intervention at p < 0.05.